RTW INVESTMENTS, LP - 31 Dec 2024 SCHEDULE 13G/A Report for SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS)

Filing Manager
RTW INVESTMENTS, LP
Reporting Manager
RTW Investments, LP
Security
SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
SABS
Shares outstanding
10,253,604 shares
Disclosed Ownership
1,024,335 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 09:00:04 UTC
Date of event
31 Dec 2024
Next filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"RTW INVESTMENTS, LP disclosed 10% ownership in SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS) on 31 Dec 2024."

Quick Takeaways

  • RTW INVESTMENTS, LP filed SCHEDULE 13G/A for SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS).
  • Disclosed ownership: 10%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 09:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RTW Investments, LP 10% 1,024,335 0 1,024,335 /s/ Roderick Wong, M.D. Roderick Wong, M.D., Managing Partner
Roderick Wong, M.D. 10% 1,024,335 0 1,024,335 /s/ Roderick Wong, M.D. Roderick Wong, M.D.

Sponsored